Abstract 1322
Background
To investigate the production and release of murine bone marrow neutrophil MMP-9 and its mechanism of activation.
Methods
Murine bone marrow neutrophils were separated and cultured in vitro and randomly divided into four groups: control group, IL-6 50ng/ml stimulation group, IL-6 50ng/ml + DMSO group and IL-6 50ng/ml + STAT3 inhibitor VIII 50 µM group. RT-PCR method was used to evaluate the mRNA level of intracellular MMP-9 of neutrophils. Gelatin zymography was performed to detect the activity of MMP-9 released from neutrophils. Western blot was applied to test the phosphorylation levels of STAT3 pathway in neutrophils.
Results
Compared with the control group, the administration of IL-6 enhanced the mRNA expression of MMP-9 (P = 0.0050); the activity of MMP-9 released from neutrophils was elevated (P = 0.0087) and the p-STAT3 levels in neutrophils was also increased (P =0.089). After the STAT3 inhibitor VIII was added, the mRNA expression of MMP-9, the activities of MMP-9 in the supernatant and the p-STAT3 levels in neutrophils were decreased significantly compared with those in the IL-6 group (P = 0.0067, 0.048 and 0.098, respectively).
Conclusions
IL-6 induces the production and releasing of MMP-9 in neutrophils and the effect may be induced by the activation of STAT3 pathway.
Clinical trial identification
Legal entity responsible for the study
Hubei Maternity and Child Health Hospital
Funding
Hubei Maternity and Child Health Hospital
Disclosure
All authors have declared no conflicts of interest.